Results 1 to 10 of about 10,508 (152)

Multifaceted oncostatin M: novel roles and therapeutic potential of the oncostatin M signaling in rheumatoid arthritis [PDF]

open access: yesFrontiers in Immunology, 2023
Rheumatoid arthritis (RA) is a self-immune inflammatory disease characterized by joint damage. A series of cytokines are involved in the development of RA.
Liang Han   +15 more
doaj   +4 more sources

Oncostatin M Modulation of Lipid Storage [PDF]

open access: yesBiology, 2015
Oncostatin M (OSM) is a cytokine belonging to the gp130 family, whose members serve pleiotropic functions. However, several actions of OSM are unique from those of other gp130 cytokines, and these actions may have critical roles in inflammatory ...
Carrie M Elks   +2 more
exaly   +5 more sources

Oncostatin M induces epigenetic reprogramming in renal cell carcinoma-associated endothelial cells [PDF]

open access: yesCommunications Biology
The molecular and functional changes in endothelial cells during disease progression such as cancer have been noted but the mechanism of their activation is still under-studied.
Hieu-Huy Nguyen-Tran   +2 more
doaj   +2 more sources

Drug Repurposing to Inhibit Oncostatin M in Crohn’s Disease [PDF]

open access: yesMolecules
Crohn’s disease is an inflammatory bowel disease (IBD) that currently lacks satisfactory treatment options. Therefore, new targets for new drugs are urgently needed to combat this disease.
Faranak Bahramimehr   +11 more
doaj   +2 more sources

Role and prognostic value of oncostatin M and its receptor OSMR in acute myeloid leukemia, myeloproliferative neoplasms and non-hematological malignancies [PDF]

open access: yesFrontiers in Oncology
The oncostatin M receptor (OSMR) has recently emerged as an adverse prognostic factor in acute myeloid leukemia (AML) and several non-hematological malignancies.
Jean-Pierre Lévesque   +3 more
doaj   +2 more sources

A bibliometric analysis of trends and hotspots in Oncostatin M [PDF]

open access: yesDiscover Oncology
Background Oncostatin M (OSM) belongs to the interleukin-6 (IL-6) cytokine family, with diverse physiological effects impacting various diseases. Despite substantial research on OSM, a systematic overview of the field’s current landscape and evolving ...
Yixuan Ning, Yanqiu Liu, Qingqing Du
doaj   +2 more sources

Oncostatin M Is Related to Polycystic Ovary Syndrome-Case Control Study [PDF]

open access: yesBiomedicines
Background: Oncostatin M, a novel adipokine, plays a role in oogenesis, lipogenesis, and inflammation and may contribute to polycystic ovary syndrome pathogenesis and related metabolic problems.
Figen Efe Camili   +6 more
doaj   +2 more sources

miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer

open access: yesCell Reports, 2019
Summary: Genomic amplification of 3q26.2 locus leads to the increased expression of microRNA 551b-3p (miR551b-3p) in triple-negative breast cancer (TNBC).
Deepak Parashar   +2 more
exaly   +3 more sources

The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review [PDF]

open access: yesOpen Life Sciences
Retinal diseases, which can lead to significant vision loss, are complex conditions involving various cellular and molecular mechanisms. The interleukin-6 (IL-6) family, particularly Oncostatin M (OSM), has garnered attention for their roles in retinal ...
Mori Tommaso   +8 more
doaj   +2 more sources

“Comparative study of serum and synovial fluid Oncostatin M level in rheumatoid arthritis and osteoarthritis patients”

open access: yesJournal of Radiation Research and Applied Sciences, 2022
Background: Rheumatoid arthritis (RA) remains a long-standing inflammatory syndrome where the joint synovial membrane is inflamed, with subsequent joint deformation. Osteoarthritis (OA) is considered to be a progressive destruction of articular cartilage
Iman H. Bassyouni   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy